Walgreen's Same-Store Sales Dive

pillsDrug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 3.9% from $6.09 billion last year to $5.85 billion.

Pharmacy sales in November fell 4.7%, and same-store pharmacy sales fell 8.8%. Pharmacy sales accounted for 63.2% of monthly sales.

Walgreen did not specifically indicate any impact from its now-resolved dispute with Express Scripts Inc. (NASDAQ: ESRX). During the nine-month fight with Express Scripts, Walgreen's lost millions of customers, and as much as 60% of the total could be gone permanently to competitor CVS Caremark Corp. (NYSE: CVS). Walgreen did say that prescriptions filled at comparable stores fell by 2.9% in November following a 1.8% drop in October.

Walgreen stock is up 2.45% this morning, at $35.12 in a 52-week range of $28.53 to $37.35, even though virtually every metric reported today was down. Even the number of flu shots administered is lower this year.

Paul Ausick

Filed under: 24/7 Wall St. Wire, Retail, Services Tagged: CVS, ESRX, WAG
Read Full Story


DJIA 25,387.18 -602.12 -2.32%
NASDAQ 7,200.87 -206.03 -2.78%
NIKKEI 225 21,810.52 -459.36 -2.06%
HANG SENG 25,792.87 159.69 0.62%
DAX 11,362.98 37.54 0.33%
USD (per EUR) 1.13 0.00 0.41%
JPY (per USD) 113.88 0.19 0.16%
GBP (per USD) 1.30 0.01 0.82%
USD (per CHF) 1.01 0.00 -0.07%